The National Institute of Pharmaceutical Education and Research (NIPER) has officially released the NIPER JEE 2026 MBA (Pharm) Shortlisted Candidates List for the next stage of the admission process. Candidates who appeared in the Computer-Based Test (CBT) conducted on 13 June 2026 can now check whether they have been shortlisted for the Group Discussion (GD) and Personal Interview (PI) round.
The shortlist includes candidates selected for the offline GD/PI process, which will be conducted at NIPER Mohali. The final admission merit list will be prepared based on the combined performance in the CBT and GD/PI rounds.
NIPER JEE 2026 MBA (Pharm) Shortlist Released
According to the official notification, a total of 525 candidates have been shortlisted for the Group Discussion and Personal Interview round. The list has been published based on Application Numbers and is not arranged according to merit rank.
Candidates are advised to carefully check their Application Number in the official PDF and prepare for the next stage of the admission process.
NIPER JEE 2026 MBA (Pharm) GD/PI Schedule
The offline Group Discussion and Personal Interview will be conducted at the Convention Centre, NIPER Mohali.
GD/PI Dates
| Candidate Range | GD/PI Date | Reporting Time |
|---|---|---|
| Serial No. 1–250 | 29 June 2026 | 7:30 AM |
| Serial No. 251–525 | 30 June 2026 | 7:30 AM |
Candidates are advised to reach Mohali at least one day before their scheduled interview date and make their own accommodation arrangements.
MBA (Pharm) Merit List Date
After completion of the GD/PI process, NIPER will prepare the final merit list based on the combined score obtained in:
- NIPER JEE 2026 CBT Score
- Group Discussion Performance
- Personal Interview Performance
Merit List Release Date
30 June 2026
NIPER MBA (Pharm) 2026 Counselling Schedule
Phase-I Counselling
- Registration & Web Options: 01 July 2026
- Seat Allotment: 02–03 July 2026
- Fee Payment & Provisional Allotment Letter: 04 July 2026
Phase-II Counselling
- Registration & Web Options: 06 July 2026
- Seat Allotment: 07–08 July 2026
- Fee Payment & Provisional Allotment Letter: 09 July 2026
Phase-II counselling will be conducted only if seats remain vacant after Phase-I.
Important Instructions for Candidates
- Carry all required original documents during GD/PI.
- Reach the venue before the reporting time.
- Arrange your own accommodation and travel.
- Candidates who secure admission in the MBA (Pharm) programme and pay the prescribed fee will not be eligible to participate in M.Pharm/M.S. (Pharm.)/M.Tech counselling.
Why Choose MBA (Pharm) at NIPER?
MBA (Pharm) is one of the most sought-after programmes for pharmacy graduates who wish to build careers in:
- Pharmaceutical Marketing
- Product Management
- Healthcare Consulting
- Pharma Sales & Business Development
- Regulatory Affairs Management
- Supply Chain & Operations Management
NIPER’s MBA (Pharm) programme offers strong industry exposure, excellent placement opportunities, and specialized training in pharmaceutical management.
Conclusion
The release of the NIPER JEE 2026 MBA (Pharm) GD/PI Shortlist marks a crucial step in the admission process. Candidates who have been shortlisted should immediately start preparing for the Group Discussion and Personal Interview rounds scheduled for 29–30 June 2026. Success in these rounds will play a significant role in securing admission to one of India’s most prestigious pharmaceutical management programmes.
Recommended Products
